etoposide has been researched along with folic acid in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 16 (64.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belinsky, MG; Chen, ZS; Kruh, GD; Rea, PA; Zeng, H | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Miyachi, H; Ohnuma, T; Sekiguchi, S; Takemura, Y | 1 |
| Bennett, M; Buamah, PK; James, OF; Lendrum, R; McArdle, P | 1 |
| Falk, M; Fridrik, MA; Haidinger, R; Hausmaninger, H; Klocker, J; Linkesch, W; Neubauer, M; Pont, J; Radaszkiewicz, T; Raudaschl, G; Schiller, L; Seewann, HL; Sill, H; Stöger, M | 1 |
| Lurain, JR | 1 |
| Clarke-Pearson, DL; Kirkpatrick, JP; Sampson, JH; Soper, JT; Spillman, M; Wolf, JK | 1 |
| Patlolla, RR; Vobalaboina, V | 1 |
| Drossopoulou, GI; Kontoyianni, C; Paleos, CM; Sideratou, Z | 1 |
| Demirbilek, M; Denkbas, EB; Güven, E; Hazer, B; Kılıçay, E; Türk, M | 1 |
| Firozian, F; Hassanzadeh, F; Sadeghi-Aliabadi, H; Varshosaz, J | 1 |
| Chen, YC; Kuo, YC | 1 |
| Kuo, YC; Lee, CH | 1 |
| Berkowitz, RS; Bernstein, MR; Goldstein, DP; Horowitz, NS; Maestá, I; Ramírez, LA | 1 |
| Jiang, H; Li, J; Lu, C; Zhang, S; Zhang, X | 1 |
| Li, JC; Liang, L; Sun, L; Tian, Y; Zhang, HM; Zhu, JX; Zhu, N | 1 |
| Chen, W; Clement, S; Deng, W; Engel, A; Goldys, EM; Guller, A; Zhao, Z | 1 |
| Alibolandi, M; Dinari, M; Khayamian, T; Ramezani, M; Rezaei, B; Shamili, FH; Shirani, MP | 1 |
| Chang, YH; Kuo, YC; Rajesh, R | 1 |
| Rajput, SJ; Saroj, S | 1 |
2 review(s) available for etoposide and folic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Management of high-risk gestational trophoblastic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Humans; Liver Neoplasms; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1998 |
1 trial(s) available for etoposide and folic acid
| Article | Year |
|---|---|
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Feasibility Studies; Female; Folic Acid; Hematologic Diseases; Humans; Ifosfamide; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Mesna; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisolone; Remission Induction; Risk Factors; Survival Rate; Vincristine | 1996 |
22 other study(ies) available for etoposide and folic acid
| Article | Year |
|---|---|
Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport.
Topics: 3T3 Cells; Animals; ATP-Binding Cassette Transporters; Biological Transport; Drug Resistance, Multiple; Folic Acid; Humans; Leucovorin; Methotrexate; Mice; Multidrug Resistance-Associated Proteins; Osmolar Concentration; Polyglutamic Acid; Tritium | 2001 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717).
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cell Line; Cisplatin; Cross Reactions; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Folic Acid; Humans; Leucovorin; Membrane Glycoproteins; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinazolines; RNA, Messenger; Thymidylate Synthase; Trimetrexate; Vincristine | 1991 |
A pleomorphic hepatocellular carcinoma with biochemical features of fibrolamellar hepatocellular carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Folic Acid; Humans; Liver Neoplasms; Neurotensin; Quinazolines; Vitamin B 12 | 1986 |
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cisplatin; Craniotomy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Staging; Pregnancy; Radiosurgery; Risk Factors; Vincristine | 2007 |
Folate-targeted etoposide-encapsulated lipid nanospheres.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Compounding; Etoposide; Fluorescent Dyes; Folic Acid; Humans; KB Cells; Lipids; Mice; Microscopy, Fluorescence; Nanospheres; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Soybean Oil; Tissue Distribution | 2008 |
Synthesis of a folate functionalized PEGylated poly(propylene imine) dendrimer as prospective targeted drug delivery system.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dendrimers; Drug Delivery Systems; Etoposide; Folic Acid; Humans; Magnetic Resonance Spectroscopy; Polyethylene Glycols; Polypropylenes; Solubility; Spectrophotometry, Ultraviolet | 2010 |
Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
Topics: 3-Hydroxybutyric Acid; Animals; Antineoplastic Agents; Apoptosis; Caproates; Cell Survival; Drug Carriers; Drug Compounding; Etoposide; Fibroblasts; Folic Acid; HeLa Cells; Humans; Immunohistochemistry; Ligands; Mice; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2011 |
Uptake of etoposide in CT-26 cells of colorectal cancer using folate targeted dextran stearate polymeric micelles.
Topics: Binding, Competitive; Cell Death; Cell Line, Tumor; Colorectal Neoplasms; Dextrans; Etoposide; Fluorescence; Folic Acid; Humans; Inhibitory Concentration 50; Micelles; Microscopy, Electron, Transmission; Polymers; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared; Stearates | 2014 |
Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Astrocytes; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Delivery Systems; Endothelial Cells; Etoposide; Folate Receptors, GPI-Anchored; Folic Acid; Glioblastoma; Humans; Lactic Acid; Lactoferrin; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, Cell Surface; Topoisomerase II Inhibitors | 2015 |
Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid.
Topics: Antineoplastic Agents, Phytogenic; Cell Survival; Etoposide; Folic Acid; Glioblastoma; Humans; Lipids; Mannose; Nanoparticles | 2015 |
Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asian; Black or African American; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Folic Acid; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Pregnancy; Risk Factors; White People; Young Adult | 2015 |
Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Etoposide; Folic Acid; Humans; Lipids; Mice; Nanomedicine; Nanostructures; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols | 2016 |
Folic Acid-Targeted Etoposide Cubosomes for Theranostic Application of Cancer Cell Imaging and Therapy.
Topics: Animals; Calorimetry, Differential Scanning; Cell Death; Cell Survival; Diagnostic Imaging; Drug Delivery Systems; Drug Liberation; Etoposide; Folic Acid; Humans; Inhibitory Concentration 50; Liquid Crystals; MCF-7 Cells; Mice; Neoplasms; Particle Size; Proton Magnetic Resonance Spectroscopy; Static Electricity; Theranostic Nanomedicine | 2017 |
Controlled gene and drug release from a liposomal delivery platform triggered by X-ray radiation.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Combined Modality Therapy; Delayed-Action Preparations; Doxorubicin; Drug Liberation; Etoposide; Fluoresceins; Folic Acid; Gene Silencing; Gold; HCT116 Cells; Humans; Liposomes; Metal Nanoparticles; Mice; Oligoribonucleotides, Antisense; PC12 Cells; Photochemotherapy; Photosensitizing Agents; Rats; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I; Singlet Oxygen; Verteporfin; X-Rays; Xenograft Model Antitumor Assays | 2018 |
Ingenious pH-sensitive etoposide loaded folic acid decorated mesoporous silica-carbon dot with carboxymethyl-βcyclodextrin gatekeeper for targeted drug delivery and imaging.
Topics: beta-Cyclodextrins; Carbon; Drug Delivery Systems; Etoposide; Folic Acid; HeLa Cells; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Molecular Docking Simulation; Nanoparticles; Silicon Dioxide | 2018 |
Targeted delivery of etoposide, carmustine and doxorubicin to human glioblastoma cells using methoxy poly(ethylene glycol)‑poly(ε‑caprolactone) nanoparticles conjugated with wheat germ agglutinin and folic acid.
Topics: Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Etoposide; Folic Acid; Glioblastoma; Humans; Nanoparticles; Polyesters; Polyethylene Glycols; Wheat Germ Agglutinins | 2019 |
Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution.
Topics: Cell Line, Tumor; Drug Carriers; Etoposide; Folic Acid; Humans; Male; Nanoparticles; Prostatic Neoplasms; Silicon Dioxide | 2018 |